CVB homepage

Product Recall

The recall includes a total of nearly 45,000 devices that should be returned to the manufacturer.

Semaglutide (Wegovy) injector pen. Photo by Dave Fornell

These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021. 

Damini Dey, PhD, FSCCT, a professor of biomedical sciences, co-associate director of the Biomedical Imaging Research Institute, and director of the quantitative image analysis program at Cedars-Sinai, explains how artificial intelligence (AI) is impacting cardiovascular imaging without most people realizing.

AI impacts care in so many ways now that it often goes unnoticed by clinicians. 

Newsweek ranked the 50 best heart hospitals in the world

Philippe Généreux, MD, presented updated findings from one of cardiology's most closely watched trials at New York Valves 2026. 

FDA recall medical device recall product recall

Specific lots of several procedure kits have been recalled after the FDA identified quality issues during a recent inspection.

the SKYWARD U.S. investigational device exemption (IDE) clinical program was launched to evaluate the Shockwave SkyRunner Carotid Intravascular Lithotripsy (IVL) System to break up carotid artery calcium prior to stenting.

Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease. 

Innovation at work

Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.  

In cooperation with CareDx